Novel OGTT metrics do not provide incremental predictive value beyond conventional glycemic criteria for remission of prediabetes in individuals with impaired fasting glucose: results from the PREVIEW trial.
Saved in:
| Title: | Novel OGTT metrics do not provide incremental predictive value beyond conventional glycemic criteria for remission of prediabetes in individuals with impaired fasting glucose: results from the PREVIEW trial. |
|---|---|
| Authors: | Zhu R; Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China., Guo J; Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China., Stratton G; Applied Sports, Technology, Exercise and Medicine (A-STEM) Research Centre, Swansea University, Swansea, UK., Macdonald IA; Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, Nottingham, UK., Handjieva-Darlenska T; Department of Pharmacology and Toxicology, Medical University of Sofia, Sofia, Bulgaria., Handjiev S; Department of Pharmacology and Toxicology, Medical University of Sofia, Sofia, Bulgaria., Navas-Carretero S; Centre for Nutrition Research, University of Navarra, Pamplona, Spain.; Centro de Investigacion Biomedica en Red Area de Fisiologia de La Obesidad y La Nutricion (CIBEROBN), Madrid, Spain.; IdisNA Instituto for Health Research, Pamplona, Spain., Poppitt SD; Human Nutrition Unit, School of Biological Sciences, Department of Medicine, University of Auckland, Auckland, New Zealand., Silvestre MP; NOVA Medical School, CINTESIS, NOVA University of Lisbon, Lisbon, Portugal., Fogelholm M; Department of Food and Nutrition, University of Helsinki, Helsinki, Finland., Adam T; Department of Nutrition and Movement Sciences, NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands., Raben A; Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark., Martinez JA; Centro de Investigacion Biomedica en Red Area de Fisiologia de La Obesidad y La Nutricion (CIBEROBN), Madrid, Spain.; Precision Nutrition and Cardiometabolic Health Program, IMDEA-Nutrition Institute (Madrid Institute for Advanced Studies), CEI UAM + CSIC, Madrid, Spain.; Department of Medicine and Endocrinology, University of Valladolid, Valladolid, Spain., Xie M; College of Information and Electrical Engineering, China Agricultural University, Beijing, 10083, China. xiemiao@cau.edu.cn., Brand-Miller J; School of Life and Environmental Sciences and Charles Perkins Centre, the University of Sydney, Camperdown, Sydney, 2006, Australia. jennie.brandmiller@sydney.edu.au. |
| Source: | Cardiovascular diabetology [Cardiovasc Diabetol] 2026 Apr 22; Vol. 25 (1). Date of Electronic Publication: 2026 Apr 22. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
